745 Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.
http://www.pnas.org/content/114/12/E2337
744 Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes.
http://stke.sciencemag.org/content/10/470/eaai8288
743 High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
http://www.pnas.org/content/114/10/2544.abstract
742 Profiling of melanoma patients treated with checkpoint blockade reveals TCR clonality and copy number loss as correlates of therapeutic response.
http://stm.sciencemag.org/content/9/379/eaah3560
741 The epidermal polarity protein Par3 is a non–cell autonomous suppressor of malignant melanoma.
http://jem.rupress.org/content/214/2/339
740 CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.
http://jem.rupress.org/content/214/2/359
739 AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy.
http://www.pnas.org/content/114/9/E1688
738 IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.
http://www.nature.com/articles/ncomms14607
737 A genome-wide association study yields five novel thyroid cancer risk loci.
http://www.nature.com/articles/ncomms14517
736 Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.
http://www.nature.com/articles/ncomms14278
735 Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.
http://www.nature.com/articles/ncomms14228
734 Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin.
http://stm.sciencemag.org/content/9/376/eaak9537
733 Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
http://stm.sciencemag.org/content/9/375/eaah6510
732 Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.
http://www.nature.com/nature/journal/v542/n7639/full/nature21052.html
731 Systemic Immunity Is Required for Effective Cancer Immunotherapy.
http://www.cell.com/cell/fulltext/S0092-8674(16)31738-X
730 Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors.
http://www.pnas.org/content/114/4/740.abstract
729 Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response.
http://immunology.sciencemag.org/content/2/7/eaah6413
728 Human tumors that display extensive chromosomal aberrations appear to be more resistant to immune attack.
http://science.sciencemag.org/content/355/6322/eaaf8399
727 Integrated genomic characterization of oesophageal carcinoma.
http://www.nature.com/nature/journal/v541/n7636/full/nature20805.html
726 Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.
http://www.nature.com/nm/journal/v23/n1/abs/nm.4232.html
|
